AI Article Synopsis
- The Génome Québec and Montreal Heart Institute Pharmacogenomics Centre, established in 2006, focuses on pharmacogenomics research and services across academia and the biotech sector, aiming to integrate these solutions into healthcare.
- The Centre boasts a multidisciplinary team skilled in genomics, bioinformatics, and clinical trials, which ensures high standards through its Good Laboratory Practice facility.
- By utilizing its technological expertise and conducting clinical trials, the Centre has successfully attracted funding and partnerships from both public and private sectors.
Article Abstract
The Génome Québec and Montreal Heart Institute Pharmacogenomics Centre (Montreal, Canada), created in 2006, is a translational pharmacogenomics platform whose main objectives are to conduct pharmacogenomics research, provide pharmacogenomics services to the academic, biotechnology and pharmaceutical sectors, and integrate pharmacogenomics solutions into the healthcare system. The Centre has brought together a multidisciplinary team of researchers with expertise in genomics, bioinformatics and clinical trial research. All the Centre's clinical research studies are supported by the Centre's unique Good Laboratory Practice facility framework, which has the ability to perform pharmaceutical clinical trials and deliver clinical diagnostics under the highest standards. The Centre has successfully leveraged its experience and expertise in technology development and pharmacogenomics clinical trial work to attract funding and collaborative partnerships in both the public and private sectors.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.2217/14622416.9.10.1391 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!